- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2662-8651
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Targeting regulatory T cells for immunotherapy in melanoma ; volume:2 ; number:1 ; day:19 ; month:4 ; year:2021 ; pages:1-15 ; date:12.2021
Molecular biomedicine ; 2, Heft 1 (19.4.2021), 1-15, 12.2021
- Creator
-
Huang, Lili
Guo, Yeye
Liu, Shujing
Wang, Huaishan
Zhu, Jinjin
Ou, Lingling
Xu, Xiaowei
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s43556-021-00038-z
- URN
-
urn:nbn:de:101:1-2021060612094471361368
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Huang, Lili
- Guo, Yeye
- Liu, Shujing
- Wang, Huaishan
- Zhu, Jinjin
- Ou, Lingling
- Xu, Xiaowei
- SpringerLink (Online service)
Other Objects (12)
New strategies for cancer immunotherapy: targeting regulatory T cells
IL-2 immunotherapy for targeting regulatory T cells in autoimmunity
Metabolic targeting of regulatory T cells in oral squamous cell carcinoma: new horizons in immunotherapy
Immunotherapy targeting esophageal cancer stem cells
Harnessing proteases for T regulatory cell immunotherapy
Immunotherapy of malignant melanoma
Regulatory cells and the effect of cancer immunotherapy
Specifically targeting ERK1 or ERK2 kills Melanoma cells
Novel vaccination strategies for CD4+ T cell immunotherapy of melanoma
Optimization of engineered T cells for the use in melanoma immunotherapy
Fibrin-Targeting Immunotherapy for Dementia
Targeting STAT3 in Cancer Immunotherapy
New strategies for cancer immunotherapy: targeting regulatory T cells
IL-2 immunotherapy for targeting regulatory T cells in autoimmunity
Metabolic targeting of regulatory T cells in oral squamous cell carcinoma: new horizons in immunotherapy
Immunotherapy targeting esophageal cancer stem cells
Harnessing proteases for T regulatory cell immunotherapy
Immunotherapy of malignant melanoma
Regulatory cells and the effect of cancer immunotherapy
Specifically targeting ERK1 or ERK2 kills Melanoma cells
Novel vaccination strategies for CD4+ T cell immunotherapy of melanoma
Optimization of engineered T cells for the use in melanoma immunotherapy
Fibrin-Targeting Immunotherapy for Dementia
Targeting STAT3 in Cancer Immunotherapy
New strategies for cancer immunotherapy: targeting regulatory T cells
IL-2 immunotherapy for targeting regulatory T cells in autoimmunity
Metabolic targeting of regulatory T cells in oral squamous cell carcinoma: new horizons in immunotherapy
Immunotherapy targeting esophageal cancer stem cells
Harnessing proteases for T regulatory cell immunotherapy
Immunotherapy of malignant melanoma
Regulatory cells and the effect of cancer immunotherapy
Specifically targeting ERK1 or ERK2 kills Melanoma cells
Novel vaccination strategies for CD4+ T cell immunotherapy of melanoma
Optimization of engineered T cells for the use in melanoma immunotherapy
Fibrin-Targeting Immunotherapy for Dementia